Financial Services » Investing & Securities | Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Inc. | Mutual Funds

Mutual Funds that own Cellular Biomedicine Group Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Russell 2000 ETF
242,922
1.43%
-129
0.01%
09/06/2018
Vanguard Extended Market Index Fund
139,059
0.82%
600
0%
07/31/2018
iShares Russell 2000 Growth ETF
77,110
0.46%
0
0.01%
09/06/2018
Bridgeway Ultra Small Company Market Fund
67,800
0.4%
0
0.33%
12/31/2017
Fidelity Spartan Extended Market Index Fund
46,609
0.28%
0
0%
07/31/2018
iShares Micro Cap ETF
31,161
0.18%
0
0.06%
09/06/2018
iShares Russell 2000 Value ETF
25,135
0.15%
0
0.01%
09/06/2018
Schwab Small Cap Index Fund
21,600
0.13%
21,600
0.01%
06/30/2018
Fidelity Spartan Total Market Index Fund
19,712
0.12%
9,959
0%
07/31/2018
15,105
0.09%
0
0.02%
07/31/2018

About Cellular Biomedicine Group

View Profile
Address
1345 Avenue of Americas
New York New York 10105
United States
Employees -
Website http://www.cellbiomedgroup.com
Updated 07/08/2019
Cellular Biomedicine Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. Its technology includes immune system therapy for treatment of cancer indications and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases The company was founded in 2009 and is headquartered in Cupertino, CA. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.